medigraphic.com

2008, Number 3

<< Back

Rev Med Inst Mex Seguro Soc 2008; 46 (3)

The Quality Control in the Coagulation Laboratory

Ruiz-de-Chávez-Ochoa AA, Núñez-Pérez E, Muñoz-Muñoz B, Majluf-Cruz A

Language: Spanish
References: 35
Page: 339-348
PDF size: 173.19 Kb.


ABSTRACT

This is a broad review of sources of error in the coagulation tests, all of which must be considered, evaluated and supervised to improve their quality. The analytical result of a laboratory examination is a scientific fact and has no medical meaning as such. It must be interpreted to become a medical finding. Recent improvement in equipment, reagents, and the fact that hemophilic and thrombotic events are considered the main causes of death are the principal reasons to prepare this article. The internal quality control program considers this fact because its beginning starts when the physician makes the request to the lab; moreover, the clinical interpretation of the results of the laboratory represents the end of the cycle. Outcome of clinical test in hemostasis is critically dependent upon the quality of the sample, the method, the instruments, the reagents and the personnel involved in the performance of the test. Use of high quality blood collection procedures and an awareness of preanalytic errors are presented to lead to quality outcomes. Today, performance of internal and external quality control programs is obligatory.


REFERENCES

  1. Smith R, Hiatt H, Berwick D. A shared statement of ethical principles for those who shape and give healthcare. A working draft from the Tavistock Group. Ann Int Med 1999;130(2)3-147. Disponible en http://www.annals.org/cgi/content/abstract/130/2/143

  2. Sandrick K. Ehics. A unifying force. The Tavistock principles provide a decision making framework for everyone. Trustee 2001;54:24-28.

  3. Levey S, Jennings ER. The use of control charts in clinical laboratories. Am J Clin Pathol 1950; 20:1059-1066.

  4. Secretaría de Salud. Norma oficial mexicana NOM-166-SSAI-1997, para la organización y funcionamiento de los laboratorios clínicos. Diario Oficial de la Federación 13 de enero de 2000.

  5. Gilbert RK. Process and analytical goals in clinical chemistry. Am J Clin Pathol 1975;63:960-973.

  6. Eilers RJ. Quality assurance in health care: Missions, goals, activities. Clin Chem 1975;21:1357-1367.

  7. Barnett RN, Mclver DD, Gorton WL. The medical usefulness of Stat test. Am J Clin Pathol 1978;69:520-524.

  8. Peabody FW. The physician and the laboratory. Boston Med Surg 1922;187:324-328.

  9. Fraser CG. Analytical goals in clinical biochemistry. Prog Clin Pathol 1981;8:101-122.

  10. Rea-Castañeda R, Gutiérrez-García JN, Díaz- Mejía GS, Kobashi-Sánchez NS, Castro- Hernández P. Estructuración de los capítulos del protocolo e investigación según el tipo de estudio. Rev Sanid Milit Mex 1987;41:245-258.

  11. Sillas-Moreno R, Enríquez-de la Fuente Trejo A, Pérez-Gómez JJ, Salas-Fernández H, González- Sánchez SM, Ressano-Pérez F, et al. Instructivo para el control de calidad en el laboratorio clínico. México. IMSS; 1982.

  12. McSwiney RR, Woodrow DA. Types of error within clinical laboratory. J Med Lab Technol 1969;26:340-346.

  13. Ewan WD. When and how to use cu-sum charts. Technometric 1963;5:1-22.

  14. Westgard JO. Better quality control through microcomputers. Diagn Med 1982;5:60-74.

  15. Westgard JO. A method evaluation decision chart (MEDx chart) for judging method performance. Clin Lab Sci 1995;8:277-283.

  16. Elodi S, Varadi K, Hollan SR. Some sources of error in the one-stage assay of factor VIII. Haemostasis 1978;7:1-9.

  17. Becan-McBide K. Laboratory sampling does the process affect the outcome. J Intraven Nurs 1999;22:137.

  18. Healy NJ, Ingram GI. The “normal range” in test of haemostasis. Thromb Haemost 1978;39:504-509.

  19. Salway JC. Metabolism at a glance. Second edition. London, England: Blackwell Science; 2000.

  20. Lippi G, Salvagno GL, Montana M, Guidi GS. Short term venous stasis influences routine coagulation testing. Blood Coagul Fibrinolysis 2005;16:453-458.

  21. Capel P, Chatelain B, Leclerq R, Lust A, Masure R, Arnout J. Quality control in haemostasis. Acta Clin Belg 1992;47:308-318.

  22. National Committee for Clinical Laboratory Standards. Procedures for the collection of diagnostic blood specimen by venipuncture. Fourth edition. Villanova, PA: Approved Standards, NCCLS Document H3-A3; 1999.

  23. Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E. The pharmacology and management of the vitamin K antagonists: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126:204S-233S.

  24. Wollner GC. Handling, storing and transporting diagnostic specimens. Lab Med 1980;11:87-90.

  25. National Committee for Clinical Laboratory Standards. Publication H4-A2. Collection, Transport and Processing of Blood Specimen for Coagulation Testing and Performance of Coagulation. Second edition. Villanova, PA: Approved Guideline. NCCLS Document H21-A2; 1991.

  26. Patterson BB, Pulis JL. Standardization of prothrombin and activated partial thromboplastin time reagents and controls. Am J Clin Path 1976; 65:213-219.

  27. Poller L, Thomson JM, Taberner DA. Effect of automation on prothrombin time test in NEQAS surveys. J Clin Pathol 1989;42:97-100.

  28. Taberner DA, Poller L, Thomson JM. Quality control of the prothrombin time and international normalized ratios. National and international schemes. Ric Clin Lab 1990;20:59-69.

  29. International Committee for Standardization in Haematology & International Committee on Thrombosis and Haemostasis. ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control. Ann Haematol 1985; 50(3):185-187.

  30. World Health Organization Expert Committee on Biological Standardization. Guidelines for thromboplastins and plasma used to control oral anticoagulant therapy. Geneva, Switzerland: WHO Tech Rep Series No. 687; 1983. p. 81.

  31. Poggio M, van den Besselaar AMHP, van der Velde EA, et al. The effect of some instruments for prothrombin time testing on the international sensitivity index (ISI) of two rabbit tissue thromboplastin reagents. Thromb Haemost 1989;62: 868-874.

  32. Patek AJ, Taylor FHC. Hemophilia. II. Some properties of a substance obtained from normal plasma effective in accelering the clotting of hemophilic blood. J Clin Invest 1937;16:113-129.

  33. Kouri T, Siloaho M. Pohjavaara S, Koskinen P, Malminiemi O, Polijanylander P, Poukka R. Preanalytical factors and measurement uncertainly. Scand J Clin Lab Invest 2005;65:463-471.

  34. Poller L. International normalized ratios (INR): the first 20 years. J Thromb Haemost 2004;2:849-860.

  35. Opartkiattikul N, Wongtiraporn W, Tientadakul P, Rungpitarungsi B. Application of indicators for quality improvement in the coagulation laboratory. Southeast Asian J Trop Med Public Health 2002;33 (Suppl 2):131-135.




2020     |     www.medigraphic.com